Mindray Medical to Exhibit at MEDICA 2010 in Dusseldorf, Germany from November 17- 20, 2010

SHENZHEN, China, Nov. 11, 2010 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced its participation in the MEDICA 2010 42nd World Forum of Medicine International Trade Fair with Congress, to be held November 17-20, 2010 in Dusseldorf, Germany. More than 135,000 visitors from well over 100 countries are expected to attend this annual event.

Mindray will exhibit more than 50 devices from its three core product segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Demonstration units of two major new products in 2010 will be presented, including the V series patient monitoring system and BS-800 chemistry analyzer.

The V series platform is a modular patient monitoring system, focusing on the philosophy of “easy-to-use” while incorporating traditionally highly complex monitoring parameters. The system is intended for intra hospital use under the direct supervision of a licensed healthcare practitioner. The system architecture allows users to customize, by removal or addition of modules, monitored parameters based on a patient’s monitoring need or acuity level.

The BS-800 Modular System combines innovation and high performance into an integrated solution. With an expandable platform, a more complete line of chemistry reagents, as well as calibrators and controls, the new solution package can be tailor-made to customer needs. Innovative features such as coaxial reagent disk, reagent bubble detection, dot light source and water quality monitor, are built in to ensure accuracy, convenience and cost-efficiency.

Mindray will also showcase a demonstration unit of BC-6800, the new generation 5-part hematology system to be launched next year. The BC-6800 is a high level auto hematology analyzer with high processing speed. In addition to the routine CBC plus 5-Part Diff WBC test, the BC-6800’s output can be extended in the form of Reticulocyte, Nucleated RBC, Optical Platelet count, etc, allowing wider clinical application and research.

Attending the conference from Mindray will be Mr. Jie Liu, Chief Operating Officer, Mr. Minghe Cheng, Chief Strategic Officer, Mr. Song Zhang, Senior Vice President of R&D, Mr. Yaoqi Zhong, Vice President of International Sales and Marketing and Mr. Ting Yang, Vice President of International and Domestic Marketing. Representing Mindray DS USA Inc. will be Ricardo Cristancho, Vice President of International Sales.Mindray will be hosting booths H9 A74 and H3 F26 at the Exhibition Ground.

“We are delighted to be attending this important international event to showcase our latest notable product launches and other promising products in the pipeline,” commented Mr. Jie Liu, Mindray’s Chief Operating Officer. “These products demonstrate that Mindray’s focus on research continues to achieve success, as well as our commitment to deliver advanced and affordable products to the markets worldwide.”

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://www.mindray.com.

SOURCE Mindray Medical International Limited